Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study

Breast Cancer Research

Volumn 10, Issue 2, 2008, Pages

  Gierach, Gretchen L ^a   Lacey Jr, James V ^a   Schatzkin, Arthur ^a   Leitzmann, Michael F ^a   Richesson, Douglas ^a   Hollenbeck, Albert R ^b   Brinton, Louise A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AARP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AROMATASE INHIBITOR; CYCLOOXYGENASE 2; ESTROGEN; ESTROGEN RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CANCER STAGING; CHEMISTRY; DIET; DRUG EFFECT; FEMALE; HEALTH BEHAVIOR; HEALTH CARE ORGANIZATION; HUMAN; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGISTER; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AROMATASE INHIBITORS; ASPIRIN; BREAST NEOPLASMS; CYCLOOXYGENASE 2; DIET; ESTROGENS; FEMALE; HEALTH BEHAVIOR; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATIONAL CANCER INSTITUTE (U.S.); NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECEPTORS, ESTROGEN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 48949119467     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2089     Document Type: Article

References (49)

1. Harris RE, Beebe-Donk J, Alshafie GA. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 2006, 6:27. 1373658, 16445867, 10.1186/1471-2407-6-27.
2. Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer 2005, 5:159. 1334211, 16343343, 10.1186/1471-2407-5-159.
3. Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am J Epidemiol 2007, 166:709-716. 10.1093/aje/kwm216, 17660454.
4. Khuder SA, Mutgi AB. Breast cancer and NSAID use: a meta-analysis. Br J Cancer 2001, 84:1188-1192. 10.1054/bjoc.2000.1709, 11336469.
5. Harris RE, Beebe-Donk J, Doss H, Burr Doss D. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 2005, 13:559-583. 15756426.
6. Bosetti C, Gallus S, La Vecchia C. Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 2006, 17:871-888. 10.1007/s10552-006-0033-7, 16841255.
7. Mangiapane S, Blettner M, Schlattmann P. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiol Drug Saf 2008, 17:115-124. 10.1002/pds.1503, 17955496.
8. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 1989, 299:1247-1250. 1838122, 2513898.
9. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 1996, 88:988-993. 10.1093/jnci/88.14.988, 8667430.
10. Friis S, Sorensen HT, McLaughlin JK, Johnsen SP, Blot WJ, Olsen JH. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 2003, 88:684-688. 10.1038/sj.bjc.6600760, 12618874.
11. Sorensen HT, Friis S, Norgard B, Mellemkjaer L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003, 88:1687-1692. 10.1038/sj.bjc.6600945, 12771981.
12. García Rodríguez LA, González-Pérez A. Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer 2004, 91:525-529. 10.1038/sj.bjc.6602003, 15226764.
13. Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 2005, 14:261-264. 10.1158/1055-9965.EPI-05-0472, 15668504.
14. Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 2007, 99:608-615. 10.1093/jnci/djk132, 17440162.
15. Vogel U, Christensen J, Nexo BA, Wallin H, Friis S, Tjonneland A. Peroxisome profilerator-activated receptorgamma2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 2007, 28:427-434. 10.1093/carcin/bgl170, 16959787.
16. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 2005, 97:805-812.
17. Friis S, Thomassen L, Sorensen HT, Tjonneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur J Cancer Prev 2008, 17:88-96.
18. Ready A, Velicer CM, McTiernan A, White E. NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Res Treat 2007, DOI 10.1007/s10549-007-9665-x, 17674199.
19. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994, 5:138-146. 10.1097/00001648-199403000-00003, 8172988.
20. Harris RE, Kasbari S, Farrar WB. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 1999, 6:71-73.
21. Johnson TW, Anderson KE, Lazovich D, Folsom AR. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev 2002, 11:1586-1591.
22. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A, . Women's Health Initiative Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 2003, 63:6096-6101. 14522941, Women's Health Initiative.
23. Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. Int J Cancer 2007, 121:211-215. 10.1002/ijc.22656, 17330846.
24. Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol 2007, 166:1150-1158. 10.1093/aje/kwm195, 17698973.
25. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005, 294:47-55. 10.1001/jama.294.1.47, 15998890.
26. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002, 94:252-266.
27. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:234S-264S. 10.1378/chest.126.3_suppl.234S, 15383474.
28. Singh-Ranger G, Salhab M, Mokbel K. The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res Treat 2007, DOI 10.1007/s10549-007-9641-5, 17624587.
29. Kadar D. Anti-inflammatory analgesics. Principles of Medical Pharmacology 1998, 410-430. New York: Oxford University Press, Kalant H, Roschlau WHE.
30. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI. association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 2004, 291:2433-2440. 10.1001/jama.291.20.2433, 15161893.
31. Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol 2005, 162:165-170. 10.1093/aje/kwi182, 15972932.
32. Moorman P, Grubber J, Millikan R, Newman B. Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 2003, 14:915-922. 10.1023/B:CACO.0000007973.59863.66, 14750530.
33. Cotterchio M, Kreiger N, Sloan M, Steingart A. Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10:1213-1217.
34. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001, 154:1119-1125. 10.1093/aje/154.12.1119, 11744517.
35. Chandrasekharan NV, Dai H, Roos KLT, Evanson NK, Tomsik J, Elton TS, Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002, 99:13926-13931. 129799, 12242329, 10.1073/pnas.162468699.
36. ICD-O-3 Coding Materials. , http://seer.cancer.gov/icd-o-3/
37. Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manage 2005, 32:70-75.
38. Thiébaut AC, Bénichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 2004, 23:3803-3820. 10.1002/sim.2098, 15580597.
39. Gail MH, Lubin JH, Rubinstein LV. Likelihood calculations for matched case-control studies and survival studies with tied death times. Biometrika 1981, 68:703-707.
40. Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S. The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med 1999, 29:72-76. 10.1006/pmed.1999.0518, 10446030.
41. Harris RE, Namboodiri K, Stellman SD, Wynder EL. Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev Med 1995, 24:119-120. 10.1006/pmed.1995.1022, 7597011.
42. Harris RE, Namboodiri KK, Farrar WB. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 1996, 7:203-205. 10.1097/00001648-199603000-00017, 8834563.
43. Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 2000, 83:112-120. 10.1054/bjoc.2000.1119, 10883678.
44. Swede H, Mirand AL, Menezes RJ, Moysich KB. Association of regular aspirin use and breast cancer risk. Oncology 2005, 68:40-47. 10.1159/000084818, 15802928.
45. Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf 2002, 11:687-693. 10.1002/pds.732, 12512245.
46. Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 2003, 12:315-326. 10.1002/pds.755, 12812012.
47. Leo C, Faber S, Hentschel B, Höckel M, Horn LC. The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. Ann Diagn Pathol 2006, 10:327-332. 10.1016/j.anndiagpath.2006.03.002, 17126249.
48. Howe LR. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res 2007, 9:210. 2206709, 17640394, 10.1186/bcr1678.
49. Mayne ST, Lippman SM. Cigarettes: a smoking gun in cancer chemoprevention. J Natl Cancer Inst 2005, 97:1319-1321.